Pengaruh Penurunan Tarif Pajak, Kesadaran Wajib Pajak Dan Modernisasi Sistem Administrasi Perpajakan Terhadap Kepatuhan Wajib Pajak UMKM Kota Metro
Expensive: Jurnal Akuntansi dan Keuangan · 2022
DOI: 10.24127/exclusive.v1i2.2995 ↗Kurz gefasst
Fachartikel in der Zeitschrift Expensive: Jurnal Akuntansi dan Keuangan, 2022. Verfasst von Nurlina Herawati und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
This study aims to determine the effect of the reduction of taxpayers, taxpayer awareness and modernization of the tax administration system on tax compliance. The type of research used is quantitative. The sample used in this study were 97 MSME taxpayers in the city of Metro. The data analysis technique used is multiple linear regression. The results showed that the reduction in tax rates had a significant effect on MSME taxpayer compliance at KPP Pratama Metro. Taxpayer awareness affects MSME taxpayer compliance at KPP Pratama Metro. Modernization of the Tax Administration System has an effect on MSME taxpayer compliance at KPP Pratama Metro
Zitieren
APA
Herawati, N., Hendri, N., & Darmayanti, E. F. (2022). Pengaruh Penurunan Tarif Pajak, Kesadaran Wajib Pajak Dan Modernisasi Sistem Administrasi Perpajakan Terhadap Kepatuhan Wajib Pajak UMKM Kota Metro. Expensive: Jurnal Akuntansi dan Keuangan. https://doi.org/10.24127/exclusive.v1i2.2995
Vancouver
Herawati N, Hendri N, Darmayanti EF. Pengaruh Penurunan Tarif Pajak, Kesadaran Wajib Pajak Dan Modernisasi Sistem Administrasi Perpajakan Terhadap Kepatuhan Wajib Pajak UMKM Kota Metro. Expensive: Jurnal Akuntansi dan Keuangan. 2022. doi:10.24127/exclusive.v1i2.2995
BibTeX
@article{Herawati2022,
author = {Herawati, Nurlina and Hendri, Nedi and Darmayanti, Elmira Febri},
title = {Pengaruh Penurunan Tarif Pajak, Kesadaran Wajib Pajak Dan Modernisasi Sistem Administrasi Perpajakan Terhadap Kepatuhan Wajib Pajak UMKM Kota Metro},
journal = {Expensive: Jurnal Akuntansi dan Keuangan},
year = {2022},
doi = {10.24127/exclusive.v1i2.2995}
}
EUVIMED